Induced inactivation of Wnt16 in young adult mice has no impact on osteoarthritis development

Osteoarthritis (OA) is a common disorder and a major cause of disability in the elderly population. WNT16 has been suggested to play important roles in joint formation, bone homeostasis and OA development, but the mechanism of action is not clear. Transgenic mice lacking Wnt16 expression (Wnt16-/-) have a more severe experimental OA than control mice. In addition, Wnt16-/- mice have a reduced cortical thickness and develop spontaneous fractures. Herein, we have used Cre-Wnt16flox/flox mice in which Wnt16 can be conditionally ablated at any age through tamoxifen-inducible Cre-mediated recombination. Wnt16 deletion was induced in 7-week-old mice to study if the Cre-Wnt16flox/flox mice have a more severe OA phenotype after destabilizing the medial meniscus (DMM surgery) than littermate controls with normal Wnt16 expression (Wnt16flox/flox). WNT16 deletion was confirmed in articular cartilage and cortical bone in Cre-Wnt16flox/flox mice, shown by immunohistochemistry and reduced cortical bone area compared to Wnt16flox/flox mice. After DMM surgery, there was no difference in OA severity in the articular cartilage in the knee joint between the Cre-Wnt16flox/flox and Wnt16flox/flox mice in neither female nor male mice. In addition, there was no difference in osteophyte size in the DMM-operated tibia between the genotypes. In conclusion, inactivation of Wnt16 in adult mice do not result in a more severe OA phenotype after DMM surgery. Thus, presence of WNT16 in adult mice does not have an impact on experimental OA development. Taken together, our results from Cre-Wnt16flox/flox mice and previous results from Wnt16-/- mice suggest that WNT16 is crucial during synovial joint establishment leading to limited joint degradation also later in life, after onset of OA. This may be important when developing new therapeutics for OA treatment.

[1]  S. Movérare-Skrtic,et al.  Wnt16 Overexpression in Osteoblasts Increases the Subchondral Bone Mass but has no Impact on Osteoarthritis in Young Adult Female Mice , 2020, Calcified Tissue International.

[2]  C. Ohlsson,et al.  Liver-derived IGF-I is not required for protection against osteoarthritis in male mice. , 2019, American journal of physiology. Endocrinology and metabolism.

[3]  S. Movérare-Skrtic,et al.  Causal Factors for Knee, Hip, and Hand Osteoarthritis: A Mendelian Randomization Study in the UK Biobank , 2019, Arthritis & rheumatology.

[4]  F. Tian,et al.  Wnt signaling: a promising target for osteoarthritis therapy , 2019, Cell Communication and Signaling.

[5]  A. Uitterlinden,et al.  Are Bone Mineral Density and Fractures Related to the Incidence and Progression of Radiographic Osteoarthritis of the Knee, Hip, and Hand in Elderly Men and Women? The Rotterdam Study , 2019, Arthritis & rheumatology.

[6]  K. Ho,et al.  Wnt16 attenuates osteoarthritis progression through a PCP/JNK-mTORC1-PTHrP cascade , 2019, Annals of the rheumatic diseases.

[7]  S. Fulzele,et al.  Pros and cons of mouse models for studying osteoarthritis , 2018, Clinical and Translational Medicine.

[8]  K. Sjögren,et al.  Inducible Wnt16 inactivation: WNT16 regulates cortical bone thickness in adult mice , 2018, The Journal of endocrinology.

[9]  R. Nusse,et al.  Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities , 2017, Cell.

[10]  F. Dell’Accio,et al.  WNT16 antagonises excessive canonical WNT activation and protects cartilage in osteoarthritis , 2016, Annals of the rheumatic diseases.

[11]  N. Lane,et al.  Optimizing tamoxifen-inducible Cre/loxp system to reduce tamoxifen effect on bone turnover in long bones of young mice. , 2015, Bone.

[12]  S. Ralston,et al.  The type 2 cannabinoid receptor regulates susceptibility to osteoarthritis in mice. , 2015, Osteoarthritis and cartilage.

[13]  W. B. van den Berg,et al.  Induction of Canonical Wnt Signaling by Synovial Overexpression of Selected Wnts Leads to Protease Activity and Early Osteoarthritis-Like Cartilage Damage. , 2015, The American journal of pathology.

[14]  S. Mohan,et al.  Role of WNT16 in the regulation of periosteal bone formation in female mice. , 2015, Endocrinology.

[15]  F. Luyten,et al.  Loss of Frzb and Sfrp1 differentially affects joint homeostasis in instability-induced osteoarthritis. , 2015, Osteoarthritis and cartilage.

[16]  A. Gelber,et al.  Osteoarthritis , 2020, Annals of Internal Medicine.

[17]  R. Baron,et al.  Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures , 2014, Nature Medicine.

[18]  Roland Baron,et al.  WNT signaling in bone homeostasis and disease: from human mutations to treatments , 2013, Nature Medicine.

[19]  David M. Evans,et al.  WNT16 Influences Bone Mineral Density, Cortical Bone Thickness, Bone Strength, and Osteoporotic Fracture Risk , 2012, PLoS genetics.

[20]  Daniel L. Koller,et al.  Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture , 2012, Nature Genetics.

[21]  C. Little,et al.  The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. , 2010, Osteoarthritis and cartilage.

[22]  C. McCulloch,et al.  High systemic bone mineral density increases the risk of incident knee OA and joint space narrowing, but not radiographic progression of existing knee OA: the MOST study , 2009, Annals of the rheumatic diseases.

[23]  J. Deng,et al.  Generation of aggrecan‐CreERT2 knockin mice for inducible Cre activity in adult cartilage , 2009, Genesis.

[24]  R. O’Keefe,et al.  Activation of β‐Catenin Signaling in Articular Chondrocytes Leads to Osteoarthritis‐Like Phenotype in Adult β‐Catenin Conditional Activation Mice , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  R. O’Keefe,et al.  Inhibition of beta-catenin signaling in articular chondrocytes results in articular cartilage destruction. , 2008, Arthritis and rheumatism.

[26]  F. Dell’Accio,et al.  Identification of the molecular response of articular cartilage to injury, by microarray screening: Wnt-16 expression and signaling after injury and in osteoarthritis. , 2008, Arthritis and rheumatism.

[27]  H Weinans,et al.  Animal models for osteoarthritis: the effect of ovariectomy and estrogen treatment - a systematic approach. , 2008, Osteoarthritis and cartilage.

[28]  J. Schrooten,et al.  Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. , 2007, Arthritis and rheumatism.

[29]  S. Glasson,et al.  The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. , 2007, Osteoarthritis and cartilage.

[30]  S. Glasson.  In vivo osteoarthritis target validation utilizing genetically-modified mice. , 2007, Current drug targets.

[31]  R. O’Keefe,et al.  Generation of a transgenic mouse model with chondrocyte‐specific and tamoxifen‐inducible expression of Cre recombinase , 2007, Genesis.

[32]  P A Dieppe,et al.  Yet more evidence that osteoarthritis is not a cartilage disease , 2006, Annals of the rheumatic diseases.

[33]  F. Dell’Accio,et al.  Activation of WNT and BMP signaling in adult human articular cartilage following mechanical injury , 2006, Arthritis research & therapy.

[34]  C. Hartmann,et al.  Wnt9a signaling is required for joint integrity and regulation of Ihh during chondrogenesis , 2006, Development.

[35]  J. Tobias,et al.  Tamoxifen stimulates cancellous bone formation in long bones of female mice. , 2005, Endocrinology.

[36]  L. Topol,et al.  Wnt/β-catenin signaling is sufficient and necessary for synovial joint formation , 2004 .

[37]  L. Southam,et al.  Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Hochberg,et al.  Bone mineral density and osteoarthritis: data from the Baltimore Longitudinal Study of Aging. , 2004, Osteoarthritis and cartilage.

[39]  Andrew P McMahon,et al.  Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. , 2002, Developmental biology.

[40]  T. Spector,et al.  The relationship of bone density and fracture to incident and progressive radiographic osteoarthritis of the knee: the Chingford Study. , 2002, Arthritis and rheumatism.

[41]  J. Gustafsson,et al.  Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Gustafsson,et al.  Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. , 1999, The Journal of clinical investigation.

[43]  S. Orkin,et al.  Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Sowers,et al.  The associations of bone mineral density and bone turnover markers with osteoarthritis of the hand and knee in pre- and perimenopausal women. , 1999, Arthritis and rheumatism.